| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.36 | 0.04 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.37 | 0.05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.082 | 0.05 |